MedPath

Study on the effect of tadalafil on bladder blood flow in patients with lower urinary tract symptoms due to benign prostatic hyperplasia

Not Applicable
Conditions
Patients with lower urinary tract symptoms due to benign prostatic hyperplasia
Registration Number
JPRN-UMIN000020658
Lead Sponsor
Hidehiro Kakizaki
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
22
Inclusion Criteria

Not provided

Exclusion Criteria

postvoid residual urine 150 ml or more, uncontrolled diabetes mellitus, patients taking medication for lower urinary tract symptoms, patients who underwent surgery or radiation to the prostate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in resistive index of vesical artery on doppler ultrasound at 8 weeks after tadalafil administration
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath